Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults.
暂无分享,去创建一个
E. Thiel | H. Heimpel | T. Büchner | R. Engelhardt | D. Hoelzer | P. Koch | H. Löffler | D. Urbanitz | H. Bodenstein | L. Plaumann
[1] F. Reyes,et al. Acute non myeloid leukaemia in adults. Prognostic factors in 92 patients. , 2009, Scandinavian journal of haematology.
[2] J. Gitlin,et al. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. , 1984, Blood.
[3] M. Desai,et al. Bone marrow transplantation for acute lymphoblastic leukaemia , 1982, British journal of haematology.
[4] G. Zei,et al. Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients. , 1982, European journal of cancer & clinical oncology.
[5] R. Storb,et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. , 1981, The New England journal of medicine.
[6] G. Kalmanson,et al. Choice of antibiotics for prophylaxis or treatment of group D streptococcal endocarditis. , 1981, The New England journal of medicine.
[7] J. Peto,et al. Immunologically Defined Subclasses of Acute Lymphoblastic Leukaemia in Children: their Relationship to Presentation Features and Prognosis , 1981, British journal of haematology.
[8] Greaves Mf,et al. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia. , 1981 .
[9] K. Foon,et al. Immunologic classification of acute lymphoblastic leukemia. Implications for normal lymphoid differentiation. , 1980, Blood.
[10] D. Huhn,et al. Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance. , 1980, Blood.
[11] J. Armitage,et al. Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. , 1980, Blood.
[12] G. Janossy,et al. Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations. , 1980, Blood.
[13] H. Thaler,et al. A long‐term clinical follow‐up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens , 1980, Cancer.
[14] W. A. Smithson,et al. Childhood acute lymphocytic leukemia , 1980, CA: a cancer journal for clinicians.
[15] F. Mandelli,et al. Combination chemotherapy for acute lymphocytic leukemia in adults: Results of a retrospective study in 82 patients , 1980 .
[16] R. Gelber,et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. , 1980, Blood.
[17] T. Lister,et al. Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases , 1980, British journal of haematology.
[18] S. Moffitt,et al. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. , 1980, Blood.
[19] M. Gobbi,et al. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia. , 1980, The New England journal of medicine.
[20] Bitran Jd. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia. , 1978 .
[21] R. Aur,et al. Childhood acute lymphocytic leukemia. Study VIII , 1978, Cancer.
[22] E. Svarch,et al. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia , 1978, Cancer.
[23] S. Sallan,et al. Acute lymphoblastic leukemia: Treatment , 1978, Cancer.
[24] G. Bodey,et al. Approaches to the treatment of acute leukemia and lymphoma in adults. , 1978, Seminars in hematology.
[25] S. Sallan,et al. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. , 1978, Blood.
[26] J. E. Freeman,et al. Combination chemotherapy for acute lymphoblastic leukaemia in adults. , 1978, British medical journal.
[27] M. Greaves,et al. ACUTE LYMPHOBLASTIC LEUKÆMIA IN CHILDREN: CLASSIFICATION AND PROGNOSIS , 1977, The Lancet.
[28] M. Greaves,et al. TERMINAL DEOXYNUCLEOTIDYL-TRANSFERASE LEVELS AND MEMBRANE PHENOTYPES IN DIAGNOSIS OF ACUTE LEUKÆMIA , 1977, The Lancet.
[29] G. Mathé,et al. CLINICAL SIGNIFICANCE AND PROGNOSTIC VALUE OF THE T-B IMMUNOLOGICAL CLASSIFICATION OF HUMAN PRIMARY ACUTE LYMPHOID LEUKÆMIAS , 1977, The Lancet.
[30] L. Borella,et al. Clinical importance of lymphoblasts with T markers in childhood acute leukemia. , 1975, The New England journal of medicine.
[31] G. Flandrin,et al. Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers. , 1975, Blood.
[32] R. Aur,et al. Combined modality therapy of acute lymphocytic leukemia , 1975, Cancer.
[33] J. Colebatch,et al. EXPERIENCES WITH CYTOSINE ARABINOSIDE IN CHILDHOOD LEUKAEMIA AND LYMPHOMA , 1971, The Medical journal of Australia.
[34] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[35] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[36] T. Lister,et al. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia. , 1981, The New England journal of medicine.
[37] G. Henze,et al. Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia. , 1981, The American journal of pediatric hematology/oncology.
[38] N. Nissen,et al. Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. , 1979, Leukemia research.
[39] M. Greaves,et al. Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. , 1977, Lancet.
[40] D.,et al. Regression Models and Life-Tables , 2022 .